The Merck’s M&A over Cubist benefits Dong-A ST
It is analyzed that the Merck’s Merger and Acquisition (M&A)with Cubist will benefit Dong-A ST.
Cubist, a pharmaceutical company specializing in antibiotics, which taken over by Merck, is a company that has acquiredthe Dong-A ST’s super antibiotic ‘Sivextro’.
A component ‘DA-7218’ developed by ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
